P53 ALTERATION CORRELATES WITH NEGATIVE ER, NEGATIVE PGR, AND HIGH HISTOLOGIC GRADE IN BREAST-CANCER

被引:9
作者
SASA, M [1 ]
KONDO, K [1 ]
KOMAKI, K [1 ]
MORIMOTO, T [1 ]
MONDEN, Y [1 ]
机构
[1] UNIV TOKUSHIMA,SCH MED SCI,TOKUSHIMA 770,JAPAN
关键词
BREAST CANCER; ER; HISTOLOGIC GRADE; P53; PGR; RT-PCR-SSCP;
D O I
10.1002/jso.2930560110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Seventy tumors of invasive ductal carcinoma of the breast were examined for p53 alteration by the RT-PCR-SSCP method. Sixty-five samples (92.9%) were investigated in the regions of codons 101-200 and 201-300. In total, 16 samples (24.6%) showed p53 gene alteration. We found that p53 gene alteration showed a correlation with (1) a negative ER status, (2) a negative PgR status, and (3) a high histologic grade (especially numerous mitotic figures) of the tumor. However, we found no correlation between p53 gene alteration and the lymph node status or clinical stage. Thus, p53 gene alteration in breast cancer may occur in highly malignant breast cancer other than advanced clinical stage cancer or node-positive cancer. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 23 条
[1]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[2]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[3]   VIMENTIN AND P53 EXPRESSION ON EPIDERMAL GROWTH-FACTOR RECEPTOR-POSITIVE, ESTROGEN RECEPTOR-NEGATIVE BREAST CARCINOMAS [J].
CATTORETTI, G ;
ANDREOLA, S ;
CLEMENTE, C ;
DAMATO, L ;
RILKE, F .
BRITISH JOURNAL OF CANCER, 1988, 57 (04) :353-357
[4]  
DAVIDOFF AM, 1991, SURGERY, V110, P259
[5]   GENETIC-BASIS FOR P53 OVEREXPRESSION IN HUMAN BREAST-CANCER [J].
DAVIDOFF, AM ;
HUMPHREY, PA ;
IGLEHART, JD ;
MARKS, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :5006-5010
[6]  
DAVIDOFF AM, 1991, CANCER RES, V51, P2605
[7]  
HARTMANN WH, 1987, HISTOLOGICAL TYPING
[8]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[9]   NUCLEAR P53 IMMUNOREACTION ASSOCIATED WITH POOR PROGNOSIS OF BREAST-CANCER [J].
IWAYA, K ;
TSUDA, H ;
HIRAIDE, H ;
TAMAKI, K ;
TAMAKUMA, S ;
FUKUTOMI, T ;
MUKAI, K ;
HIROHASHI, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (07) :835-840
[10]   MUTATIONS IN THE P53 TUMOR SUPPRESSOR GENE IN PRIMARY LUNG-CANCER IN JAPAN [J].
KONDO, K ;
UMEMOTO, A ;
AKIMOTO, S ;
UYAMA, T ;
HAYASHI, K ;
OHNISHI, Y ;
MONDEN, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (03) :1139-1146